TY - JOUR
T1 - Brief strategic family therapy™ for adolescent drug abusers
T2 - A multi-site effectiveness study
AU - Robbins, Michael S.
AU - Szapocznik, José
AU - Horigian, Viviana E.
AU - Feaster, Daniel J.
AU - Puccinelli, Marc
AU - Jacobs, Petra
AU - Burlew, Kathy
AU - Werstlein, Robert
AU - Bachrach, Ken
AU - Brigham, Greg
PY - 2009/5
Y1 - 2009/5
N2 - Brief strategic family therapy™ (BSFT) is a manualized treatment designed to address aspects of family functioning associated with adolescent drug use and behavior problems (J. Szapocznik, U. Hervis, S. Schwartz, (2003). Brief strategic family therapy for adolescent drug abuse. (NIH Publication No. 03-4751). Bethesda, MD: National Institute on Drug Abuse). Within the National Institute on Drug Abuse's (NIDA's) Clinical Trials Network, BSFT is being compared to treatment as usual (TAU) in a multisite, prospective randomized clinical trial for drug using adolescents and their families in outpatient settings. The effectiveness of BSFT is being compared to TAU in reducing adolescent drug use, conduct problems, and sexually risky behaviors as well as in improving family functioning and adolescent prosocial behaviors. This paper describes the following aspects of the study: specific aims, research design and study organization, assessment of primary and secondary outcomes, study treatments, data analysis plan, and data monitoring and safety reporting.
AB - Brief strategic family therapy™ (BSFT) is a manualized treatment designed to address aspects of family functioning associated with adolescent drug use and behavior problems (J. Szapocznik, U. Hervis, S. Schwartz, (2003). Brief strategic family therapy for adolescent drug abuse. (NIH Publication No. 03-4751). Bethesda, MD: National Institute on Drug Abuse). Within the National Institute on Drug Abuse's (NIDA's) Clinical Trials Network, BSFT is being compared to treatment as usual (TAU) in a multisite, prospective randomized clinical trial for drug using adolescents and their families in outpatient settings. The effectiveness of BSFT is being compared to TAU in reducing adolescent drug use, conduct problems, and sexually risky behaviors as well as in improving family functioning and adolescent prosocial behaviors. This paper describes the following aspects of the study: specific aims, research design and study organization, assessment of primary and secondary outcomes, study treatments, data analysis plan, and data monitoring and safety reporting.
KW - Adolescent
KW - BSFT™
KW - Drug abuse
KW - Effectiveness trial
KW - Manualized
UR - http://www.scopus.com/inward/record.url?scp=67349242582&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67349242582&partnerID=8YFLogxK
U2 - 10.1016/j.cct.2009.01.004
DO - 10.1016/j.cct.2009.01.004
M3 - Article
C2 - 19470315
AN - SCOPUS:67349242582
VL - 30
SP - 269
EP - 278
JO - Contemporary Clinical Trials
JF - Contemporary Clinical Trials
SN - 1551-7144
IS - 3
ER -
